Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer

Abstract

Our findings provide evidence for an association between levels of a biomarker, osteopontin, and ovarian cancer and suggest that future research assessing its clinical usefulness would be worthwhile.